Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice.
Marie Pieronne-DeperroisAlexandre GuéretZoubir DjeradaClément CrochemoreNajah HaroukiJean-Paul HenryAnaïs DumesnilMarine LarchevêqueJean-Claude do RegoJean-Luc do RegoLionel NicolVincent RichardFrédéric JaisserPeter KolkhofPaul MulderChristelle MonteilAntoine Ouvrard-PascaudPublished in: ESC heart failure (2021)
Finerenone improved cardiovascular dysfunction and exercise capacity after ovariectomy-induced LV diastolic dysfunction with preserved ejection fraction.